Loading clinical trials...
Loading clinical trials...
Mobile Lung Nodule Observatory for Worldwide, Evidenced - Based Research
Patients with lung nodules may develop a variety of potentially severe symptoms. These symptoms may impact a patient's quality of life and lead to difficult treatment. Through this research program, the investigators want to understand the pathogenesis of the changes of these symptoms.
Lung nodules can manifest as single or multiple independent lung consolidation shadow in form of quasi-circular. These lung nodules are surrounded by normal lung tissues, and will not cause pulmonary atelectasis. In some early standards, all the quasi-circular shadows within 6cm found in lung are categorized as lung nodules. However, according to current standards, the lesion within 3cm can be identified as lung nodules. With widespread use of lung cancer CT screening, lung nodules were identified more and more frequently. What is the optimal way to manage this CT finding? Should we adopt surgical removal or just observation? An optimal solution is to determine a clearly defined standard of care that is easy to learn. We propose a method called "three plus two". The 'Three' is a three-step testing method, and the 'Two' means two alternative solutions. Three-step testing method includes collecting medical history, non-invasive examination, and invasive examination. The two alternative solutions are surgical removal and follow-up observation. We have independently developed an application based on a smartphone platform. This platform will provide a novel evidence-based research method for observing the dynamic evolution of the lung nodules in patients. There have been no prior studies about managing this CT scan finding, either in China or internationally.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Beijing Union Hospital
Beijing, China
General Hospital of PLA
Beijing, China
Hebei Pronvince Cangzhou City People's Hospital
Cangzhou, China
Xiaya Hospital Central South Unversity
Changsha, China
Anhui Province Chaoyang Hospital
Chaoyang, China
West China Hospital Sichuan University
Chengdu, China
No.1 Hospital Chongqing Medical University
Chongqing, China
Western East Hospital No. 3 PLA Medical University
Chongqing, China
No. 2 Hospital Dalian Medical University
Dalian, China
Guizhou Province People's Hospital
Guizhou, China
Start Date
October 1, 2015
Primary Completion Date
October 1, 2025
Completion Date
October 1, 2025
Last Updated
August 7, 2018
10,000
ESTIMATED participants
Installation or registration of smartphone application
OTHER
Lead Sponsor
Chinese Alliance Against Lung Cancer
NCT02448225
NCT02726633
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions